For instance, the administration of GLP-1 nanomedicine resulted in a decrease in IL-1, a pro-inflammatory cytokine, and a marked improvement of the architecture of the intestinal epithelium in a colitis model [223]
demonstrated that GLP-1RAs are associated with significantly lower risks of pneumonia and severe sepsis in patients with type 2 diabetes compared to dipeptidyl peptidase-4 inhibitors (DPP-4is)
Early diagnosis and adequate treatment can be helpful in controlling the symptoms and preventing long-term problems
However, Asia-Pacific emerges as the fastest-growing region, fueled by rapidly increasing diabetes prevalence, expanding middle-class populations, and improving healthcare access in countries like China and India
Cmo tomarla: 3045 min antes de entrenar, posible uso en ayunas, y 2 tomas/da para niveles estables